Investors
Oxurion/Investors/News

Investor news.

Regulated information, press releases and inside information published by Oxurion. Documents are available as PDF in English, Dutch and French.

464 press releases
14 Sep 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
28 Aug 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
21 Jul 2026

Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV

ENFR
14 Jul 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
8 Jul 2026
Regulated

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

ENNL
6 Jul 2026

Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module

ENNLFR
26 Jun 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
24 Jun 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
18 Jun 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
15 Jun 2026

Major market validation: Pierre Fabre Laboratories use Oxurion's Exagis platform

ENFRNL
10 Jun 2026
RegulatedTransparency/Denominator

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
8 Jun 2026

Oxurion launches a software-driven growth strategy with Exagis

ENFR
…